Professor Ibram X. Kendi is packing up shop and leaving Boston University, but the antiracism grift is not over yet. On ...
Takeda Pharmaceutical's strong earnings, dividends, and strategic moves make it an appealing investment despite US policy ...
A 10-story office building in downtown Boston has been acquired by some familiar faces: the property’s former owners.